DAMANHOUR UNIVERSITY
🇪🇬Egypt
- Country
- 🇪🇬Egypt
- Ownership
- -
- Established
- 2010-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.damanhour.edu.eg
Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy
Not Applicable
Completed
- Conditions
- Diabetes MellitusIschemic Cardiomyopathy
- Interventions
- Other: Placebo TabletDrug: Alpha Lipoic Acid 600 MG Oral Tablet
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Damanhour University
- Target Recruit Count
- 60
- Registration Number
- NCT06056687
- Locations
- 🇪🇬
Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes., Damanhūr, Elbehairah, Egypt
Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.
- First Posted Date
- 2023-09-11
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Damanhour University
- Target Recruit Count
- 100
- Registration Number
- NCT06030895
- Locations
- 🇪🇬
Mansoura University Hospital, Mansoura, El-Dakahelia, Egypt
Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer
Not Applicable
Completed
- Conditions
- Breast CancerDoxorubicin Induced Cardiotoxicity
- Interventions
- Other: Placebo
- First Posted Date
- 2023-07-25
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Damanhour University
- Target Recruit Count
- 50
- Registration Number
- NCT05959889
- Locations
- 🇪🇬
Damanhour Oncology Center, Damanhūr, Elbehairah, Egypt
Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting
- First Posted Date
- 2023-06-23
- Last Posted Date
- 2023-06-23
- Lead Sponsor
- Damanhour University
- Target Recruit Count
- 151
- Registration Number
- NCT05916105
- Locations
- 🇪🇬
Rehab Hussein Werida, Damanhūr, Elbehairah, Egypt
Association Between Inflammatory Biomarkers in CVD Patients on Empagliflozin.
Completed
- Conditions
- Heart FailureStable Angina
- Interventions
- Other: Group I HealthyDrug: CAD-Empagliflozin 10 mg once daily for 6 months before the beginning of the studyDrug: HF-Empagliflozin 10 mg once daily for 6 months before the beginning of the study
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Damanhour University
- Target Recruit Count
- 180
- Registration Number
- NCT05911724
- Locations
- 🇪🇬
Tanta University Hospital, Tanta, El-Gharbia, Egypt
Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients
Phase 2
Completed
- Conditions
- ST-segment Elevation Myocardial Infarction
- Interventions
- First Posted Date
- 2023-06-08
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Damanhour University
- Target Recruit Count
- 80
- Registration Number
- NCT05895123
- Locations
- 🇪🇬
Damanhour University, Damanhūr, Egypt
Sacubitril/Valsartan Versus Valsartan in Heart Failure
Phase 4
Completed
- Conditions
- Heart Failure
- Interventions
- First Posted Date
- 2023-05-31
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Damanhour University
- Target Recruit Count
- 80
- Registration Number
- NCT05881720
- Locations
- 🇪🇬
Tanta University Hospital, Tanta, Elgarbia, Egypt
Assessment of Safety and Satisfaction Toward COVID-19 Vaccines.
Completed
- Conditions
- COVID-19 Vaccine Adverse Reaction
- First Posted Date
- 2023-05-12
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- Damanhour University
- Target Recruit Count
- 508
- Registration Number
- NCT05857176
- Locations
- 🇪🇬
Rehab Hussein Werida, Damanhūr, Elbehairah, Egypt
Valproic Acid Use in Patients With Neurological Disorders
Not Applicable
Completed
- Conditions
- Neurological Disorders
- First Posted Date
- 2023-04-26
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Damanhour University
- Target Recruit Count
- 600
- Registration Number
- NCT05830981
Fenofibrate Role in Breast Cancer Patients
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Damanhour University
- Target Recruit Count
- 50
- Registration Number
- NCT05813145
- Locations
- 🇪🇬
Damanhour Oncology Center, Damanhūr, Elbehairah, Egypt